Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review

  • Georgios Kalambokis
  • Areti Theodorou
  • Paraskevi Kosta
  • Epameinondas V. Tsianos
Case Report

Abstract

Pyomyositis is infrequently reported in patients with multiple myeloma. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is emerging as an important cause of soft tissue infections, including pyomyositis. Here, we report on the first case of CA-MRSA pyomyositis in a patient with multiple myeloma and review the relevant literature.

Keywords

Multiple myeloma Pyomyositis Community-acquired MRSA 

References

  1. 1.
    Sirohi B, Powles R. Multiple myeloma. Lancet. 2004;363:875–87.PubMedCrossRefGoogle Scholar
  2. 2.
    Paradisi F, Corh G, Cinelli R. Infections in multiple myeloma. Infect Dis Clin North Am. 2001;15:373–84.PubMedCrossRefGoogle Scholar
  3. 3.
    Savage DG, Lindenbaum J, Garret TJ. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med. 1982;96:47–50.PubMedGoogle Scholar
  4. 4.
    Sarubbi FA, Gafford GD, Bishop DR. Gram-negative bacterial pyomyositis: unique case and review. Rev Infect Dis. 1989;11:789–92.PubMedGoogle Scholar
  5. 5.
    Prallet B, Cartry O, Tonolli I, et al. Bacterial pyomyositis in a patient with a multiple myeloma. Clin Rheumatol. 1992;11:424–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Korten V, Gurbuz O, Firatli T, Bayik M, Akoglou T. Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage. J Chemother. 1992;4:225–7.PubMedGoogle Scholar
  7. 7.
    Hoyle C, Goldman M. Pyomyositis in a patient with myeloma responding to antibiotics alone. J Intern Med. 1993;233:419–21.PubMedCrossRefGoogle Scholar
  8. 8.
    Katagiri K, Shibuya H, Takayasu S. Bacteroides fragilis pyomyositis in a patient with multiple myeloma. J Dermatol. 1996;23:129–32.PubMedGoogle Scholar
  9. 9.
    Cone LA, Lamb RB, Graff-Radford A, et al. Pyomyositis of the anterior tibial compartment. Clin Infect Dis. 1997;25:146–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Matsuno O, Matsumoto T, Miyazaki E, Nakagawa H, Kumamoto T, Tsuda T. Pyomyositis associated with Bacteroides fragilis in a patient with multiple myeloma. Am J Trop Med Hyg. 1998;59:42–4.PubMedGoogle Scholar
  11. 11.
    Moran JG, Krishnadasan A, Gorwitz JR, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74.PubMedCrossRefGoogle Scholar
  12. 12.
    Tristan F, Etienne J. Community acquired MRSA in Europe. BMJ. 2007;335:947–8.CrossRefGoogle Scholar
  13. 13.
    Fan HC, Lo WT, Chu ML, Wang CC. Clinical characteristics of Staphylococcal pyomyositis. J Microbiol Immunol Infect. 2002;35:121–4.PubMedGoogle Scholar
  14. 14.
    Ruiz ME, Yohannes S, Wladyka CG. Pyomyositis caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2005;352:1488–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Fowler A, Mackay A. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user. J Med Microbiol. 2006;55:123–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Martin-Millan M, Garcia-Ibarbia C, Gutierrez-Cuadra M, et al. Pyomyositis: retrospective review in a third-level hospital in the north of Spain. Enferm Infecc Microbiol Clin. 2006;24:173–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Small LN, Ross JJ. Tropical and temperate pyomyositis. Infect Dis Clin North Am. 2005;19:981–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2007;13:594–600.PubMedGoogle Scholar
  19. 19.
    Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976–84.PubMedCrossRefGoogle Scholar
  20. 20.
    Issartel B, Tristan A, Lechevallier S, et al. Frequent carriage of Panton–Valentine leukocidin genes by Staphylococcus aureus isolates from surgically drained abscesses. J Clin Microbiol. 2005;43:3203–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton–Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–32.PubMedCrossRefGoogle Scholar
  22. 22.
    Davis SL, Perri B, Donabedian SM, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol. 2007;45:1705–11.PubMedCrossRefGoogle Scholar
  23. 23.
    Twomey JJ. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med. 1973;132:562–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Hargreaves RM, Lea JR, Griffiths H, et al. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol. 1995;48:260–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Perri RT, Hebbel RP, Oken MM. Influence of treatment and response status on infection risk in multiple myeloma. J Am Med Assoc. 1981;71:935–40.Google Scholar

Copyright information

© The Japanese Society of Hematology 2008

Authors and Affiliations

  • Georgios Kalambokis
    • 1
  • Areti Theodorou
    • 1
  • Paraskevi Kosta
    • 2
  • Epameinondas V. Tsianos
    • 1
  1. 1.First Division of Internal MedicineMedical School of Ioannina, University HospitalIoanninaGreece
  2. 2.Department of RadiologyUniversity HospitalIoanninaGreece

Personalised recommendations